Selective Cell and Network Vulnerability in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The goal of this FOA is to define and characterize neural cell populations, neural circuits, and brain networks and regions that are vulnerable to brain aging and Alzheimer's disease (AD). Understanding mechanisms underlying selective vulnerability from cells to networks in AD is critical to fully define the disease process and to develop effective therapies.


  • Letter of Intent Due Date(s): 30 days before the application due date
  • R01 Due Dates: Feb. 5, Jun. 5, Oct. 5

PAR-18-706 Expiration Date November 6, 2019




Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science

External Deadline

October 5, 2019